SCHEMBL31508142

SCHEMBL31508142

Nc1ccn([C@@H]2CCOC2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.33
PIK3CA P42336 6/20 0.33
SRC P12931 5/20 0.33
PIK3CD O00329 4/20 0.33
ABL1 P00519 4/20 0.33
EGFR P00533 4/20 0.33
HCK P08631 4/20 0.33
PIK3CB P42338 4/20 0.33
MTOR P42345 4/20 0.33
PIK3CG P48736 4/20 0.33
EPHB4 P54760 4/20 0.33
PRKDC P78527 4/20 0.33
PI4KB Q9UBF8 4/20 0.33
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
LRRK2 Q5S007 4/20 0.33
RET P07949 2/20 0.33
MCHR1 Q99705 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
JAK2 O60674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20555738 0.90 SIGMAR1 (0.36) PIK3CAPIK3CDPIK3CBPIK3CGFAAH
SCHEMBL17506671 0.89 FAAH (0.40) FAAHMGLLLRRK2RETSIGMAR1
SCHEMBL24884453 0.85 KIT (0.33) SIGMAR1
SCHEMBL20456694 0.79 FAAH (0.33) PIK3CAFAAHMGLLLRRK2SIGMAR1
SCHEMBL20456693 0.79 FAAH (0.33) PIK3CAFAAHMGLLLRRK2SIGMAR1
SCHEMBL24884253 0.79 MAP3K12 (0.34) PIK3CAMTORLRRK2SIGMAR1MAP3K12
SCHEMBL24915326 0.77 FAAH (0.34) KDRPIK3CASRCPIK3CDABL1
SCHEMBL22497231 0.76 SOST (0.34) KDRPIK3CASRCPIK3CDABL1
SCHEMBL3246939 0.76 SIGMAR1 (0.36) SIGMAR1
SCHEMBL3432373 0.76 SIGMAR1 (0.39) PI4KBSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384773-B2 Thiazole compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2025-08-12 US disclosed
WO-2025096979-A1 THIAZOLE COMPOUNDS AS KIT INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 WO disclosed
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384773-B2 Thiazole compounds and methods of use thereof TPMT, CYP11B2, ABAT KDR 4203/4885PIK3CA 3424/4885SRC 1808/4885
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF TPMT, CYP11B2, ABAT KDR 4203/4885PIK3CA 3424/4885SRC 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.